PMPRB Consultation On August 5, the CLHIA responded to the June 20 Patented Medicines Pricing Review Board (PMPRB) consultation on its revised draft guidelines. The Guidelines will support the government’s implementation of the amended Patented Medicines Regulations planned for January 1, 2021. The CLHIA continued to provide the industry’s support for the planned reforms. We indicated that in our view, the proposed changes strike the right balance between reducing the high cost of prescription drugs in Canada, while also continuing to ensure Canadians have access to affordable and necessary medications. We also reinforced the importance of moving forward as planned on January 1, 2021 without further delays. CLHIA will continue to monitor for any updates. The final guidelines are expected to be available in the next few months in preparation for the January 1 implementation.